proactiveinvestors.com

Immunic Names Elena Ridloff to Board of Directors

Immunic logoImmunic
Sig1.60Sen+2.00Env0.00Soc0.00Gov+2.40

Immunic has appointed Elena Ridloff to its board of directors. The company said it expects top-line data from its Phase 3 ENSURE trials in relapsing multiple sclerosis by year-end and plans to begin a confirmatory Phase 3 program in progressive MS. Management said Ridloff’s biopharma experience will support efforts to advance vidofludimus calcium across MS patient populations.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro